Principal Investigators

Benjamin G. Neel, MD, PhD
Professor of Medicine, NYU School of Medicine
Director, Laura and Isaac Perlmutter Cancer Center
contact :


Toshiyuki Araki, PhD Toshi Araki
Research Assistant Professor
Ph.D., 2000, Protein Research Institute, Suita Japan
My work focuses on the Role of RAS/ERK signaling in human development and cancers.
contact :

Post Doctoral Fellows

Abhishek Bhardwaj
Post-Doctoral Fellow
Ph.D., 2016, National Institute of Immunology, JNU, New Delhi/ India
Investigating the role of PTP1B  in regulating RNF213, the identification and function of RNF213 substrates and the detailed mechanism of RNF213 ubiquitin ligase activity.
contact :

Carmine Fedele
Post-Doctoral Fellow
Ph.D., 2012, University of Naples Federico II, Naples, Italy
Investigating the detailed mechanism of action of SHP2 inhibitors in breast cancer; identifying other vulnerabilities in TNBC
contact :

Mitchell Geer
Post-Doctoral Fellow
Ph.D., 2017, University of Birmingham, UK
I am studying kinase-phosphatase mediated signaling in leukemia development, particularly the role of specific ERK isoforms in normal hematopoiesis and myeloproliferative disorders.
contact :

Jayu Jen
Post-Doctoral Fellow
Ph.D., 2015, National Cheng Kung University, Tainan, Taiwan
I am studying autophagy-mediated tumor progression and tumor microenvironment modulation.
contact :

Kwan Ho Tang
Ph.D., 2013, Chinese Academy of Science, Beijing, China
Post-Doctoral Fellow
Ph.D., University of Hong Kong
I am studying the effects of SHP2 inhibitors on the tumor microenvironment in lung and pancreas cancer, and also using scRNAseq to define cellular hieracrchies in normal fallopian tube and ovarian cancer.
contact :


Wei Wei
Graduate Student
MS of Biology from NYU, 2014
I studying mechanisms of cancer cell resistance to SHP2 inhibitors.
contact :

Connor Foster
MD/PhD Student
BA in Biological Sciences from Cornell University, 2015
I study the role of PZR in the immune system as well as the role of shp2 binding proteins in downregulating the immune response in cancer.

Laboratory Manager

Kiyomi Araki, Ph.D.
contact :